GO
Loading...
 

GSK Will Defend Tier Pricing: CEO

Thu 18 Oct 12 | 07:40 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

GSK Will Defend Tier Pricing: CEO

Thu 18 Oct 12 | 07:40 PM ET
Andrew Witty, Global CEO, GlaxosmithKline speaks to CNBC TV-18's Shereen Bhan on the current patent price debate in the drug industry. He states GSK will continue striving to defend tier pricing.
 
RELATED ARTICLES AND CONTENT
More Videos
Go
Displaying results for: Latest Video | US